Zofran and Soy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zofran (ondansetron hydrochloride) and Soy (soy). Common drug interactions include stevens-johnson syndrome among females and abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Zofran and Soy. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

What is Soy?

Soy has active ingredients of soy. eHealthMe is studying from 562 Soy users. Check the latest studies of Soy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

14 people who take Zofran and Soy together, and have interactions are studied.

What are the common drug interactions of Zofran and Soy, by gender? *:

female:

Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Blood iron decreased
Decreased appetite
Eating disorder
Thrombosis (formation of a blood clot inside a blood vessel)
Weight decreased
Weight fluctuation
Cardiomyopathy (weakening of the heart muscle)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

male:

Abscess (pus)
Anxiety
Fracture
Injury
Neuropathy peripheral (surface nerve damage)
Oral herpes (viral infection of mouth)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain
Poor dental condition

What are the common drug interactions of Zofran and Soy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Constipation
Dental caries
Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
Fracture
Injury
Neuropathy peripheral (surface nerve damage)
Oral herpes (viral infection of mouth)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain

50-59:

Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Female genital tract fistula (passage in genital tract of female)

60+:

n/a

What are the existing conditions these people have? *

Bone Erosion: 6 people, 42.86%
Pathological Fracture (broken bone caused by disease): 6 people, 42.86%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 6 people, 42.86%
Pain: 4 people, 28.57%
Hypokalemia (low potassium): 3 people, 21.43%
Dyspnea (difficult or laboured breathing): 3 people, 21.43%
Fungal Infection: 3 people, 21.43%
Heart Disease: 3 people, 21.43%
Hyperglycemia (high blood sugar): 3 people, 21.43%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Zofran and Soy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously